Bio-Connect

Anti-ZIKV E domain III [SMZAb1]

Ab01256-10.0
Absolute Antibody
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Absolute Antibody
  • Product Name
    Anti-ZIKV E domain III [SMZAb1]
  • Delivery Days Customer
    7
  • Antibody Specificity
    SMZAb1 binds to domain III of the ZIKV E protein.
  • Application Supplier Note
    ELISA was used to confirm SMZAb1 binds to the ZIKV E domain, and neutralisation assays identified the IC50 of SMZAb1 as 5.4 ng/ml. Four macaques were injected with a cocktail of anti-Zika antibodies (SMZAb1, SMZAb2, SMZAb5) and then infected with ZIKV virus. The antibody cocktail appeared to confer sterilising immunity on the treated macaques and completely prevented viral replication, which was not seen with the control group (Magnani et al, 2017).
  • Applications
    ELISA, Neutralisation/Blocking
  • Applications Supplier
    ELISA; therapeutic; neutralisation assays
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    SMZAb1
  • Host
    Human
  • Isotype
    IgG1
  • Protein IDQ91KX7
  • Protein Name
    Envelope protein
  • Scientific Description
    This reformatted human antibody was made using the variable domain sequences of the original Human IgG format, for improved compatibility with existing reagents, assays and techniques.
  • Reactivity
    Virus
  • Reactivity Supplier
    Zika virus
  • Reactivity Supplier Note
    Antibody genes were cloned from blood-derived plasmablasts of a ZIKV-infected human subject from Colombia in the acute phase. Amplified heavy and light chains were tested for neutralisation, and SMZAb1 was selected from this.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203